Online Only Articles

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA;Howard Hughes Medical Institute, Portland, OR, USA;Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, USA
Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA;Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA
Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA
Vol. 103 No. 8 (2018): August, 2018 https://doi.org/10.3324/haematol.2018.190926